CHPF
Basic information
Region (hg38): 2:219538954-219543809
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHPF gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 50 | 53 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 50 | 2 | 2 |
Variants in CHPF
This is a list of pathogenic ClinVar variants found in the CHPF region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-219539397-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
2-219539432-G-T | not specified | Uncertain significance (Oct 14, 2023) | ||
2-219539477-T-G | not specified | Uncertain significance (Jun 22, 2024) | ||
2-219539490-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
2-219539499-C-T | not specified | Uncertain significance (May 18, 2023) | ||
2-219539517-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
2-219539522-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
2-219539546-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
2-219539565-T-C | not specified | Likely benign (Dec 03, 2021) | ||
2-219539577-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
2-219539580-A-T | not specified | Uncertain significance (Aug 04, 2023) | ||
2-219539612-T-A | not specified | Uncertain significance (Oct 06, 2021) | ||
2-219539613-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
2-219539614-C-T | Benign (Dec 31, 2019) | |||
2-219539616-C-G | not specified | Uncertain significance (Sep 29, 2023) | ||
2-219539619-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
2-219539619-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
2-219539625-C-G | not specified | Uncertain significance (May 23, 2023) | ||
2-219539685-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
2-219539765-G-C | not specified | Uncertain significance (Apr 01, 2024) | ||
2-219539785-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
2-219539800-C-G | not specified | Uncertain significance (Jan 04, 2022) | ||
2-219539831-C-T | not specified | Uncertain significance (Jul 11, 2023) | ||
2-219539868-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
2-219539969-C-T | not specified | Uncertain significance (Feb 17, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHPF | protein_coding | protein_coding | ENST00000243776 | 4 | 4841 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.151 | 0.849 | 125678 | 0 | 68 | 125746 | 0.000270 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.03 | 419 | 483 | 0.868 | 0.0000317 | 4803 |
Missense in Polyphen | 87 | 113.4 | 0.7672 | 1155 | ||
Synonymous | 1.18 | 188 | 210 | 0.896 | 0.0000125 | 1762 |
Loss of Function | 3.33 | 6 | 23.4 | 0.257 | 0.00000143 | 218 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000364 | 0.000360 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000508 | 0.000484 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.0000688 | 0.0000653 |
Other | 0.000171 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Has both beta-1,3-glucuronic acid and beta-1,4-N- acetylgalactosamine transferase activity. Transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Isoform 2 may facilitate PRKN transport into the mitochondria. In collaboration with PRKN, isoform 2 may enhance cell viability and protect cells from oxidative stress. {ECO:0000269|PubMed:12761225}.;
- Pathway
- Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human);Metabolism of carbohydrates;Chondroitin sulfate biosynthesis;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;chondroitin sulfate biosynthesis (late stages);Proteoglycan biosynthesis;chondroitin sulfate biosynthesis;dermatan sulfate biosynthesis;Metabolism;chondroitin and dermatan biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.196
Intolerance Scores
- loftool
- rvis_EVS
- -0.86
- rvis_percentile_EVS
- 10.89
Haploinsufficiency Scores
- pHI
- 0.140
- hipred
- Y
- hipred_score
- 0.597
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.323
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chpf
- Phenotype
- limbs/digits/tail phenotype; skeleton phenotype; normal phenotype;
Gene ontology
- Biological process
- chondroitin sulfate biosynthetic process
- Cellular component
- Golgi membrane;mitochondrial matrix;cytosol;integral component of membrane;Golgi cisterna membrane
- Molecular function
- metal ion binding;glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity